Onset and duration of action of rocuronium in children receiving chronic anticonvulsant therapy

Paediatric Anaesthesia

Volumn 10, Issue 2, 2000, Pages 133-136

  Soriano, Sulpicio G ^a   Kaus, Sarah J ^a   Sullivan, Lorna J ^a   Martyn, J A Jeevendra ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Epilepsy; Nondepolarizing neuromuscular relaxants; Rocuronium

Indexed keywords

CARBAMAZEPINE; PHENYTOIN; ROCURONIUM;

ADOLESCENT; ANTICONVULSANT THERAPY; ARTICLE; CHILD; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RESISTANCE; ELECTROMYOGRAPHY; EPILEPSY; HUMAN; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR TRANSMISSION; PRIORITY JOURNAL; THENAR;

ANALYSIS OF VARIANCE; ANDROSTANOLS; ANESTHESIA RECOVERY PERIOD; ANTICONVULSANTS; CARBAMAZEPINE; CASE-CONTROL STUDIES; CHILD; DRUG INTERACTIONS; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; EPILEPSY; EVOKED POTENTIALS, MOTOR; HUMANS; INJECTIONS, INTRAVENOUS; MUSCLE CONTRACTION; MUSCLE, SKELETAL; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PHENYTOIN; SYNAPTIC TRANSMISSION; THUMB; TIME FACTORS;

EID: 0034061331     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2000.00472.x     Document Type: Article

References (17)

1. 1 Scheuer ML, Pedley TA. The evaluation and treatment of seizures. N Engl J Med 1990; 323: 1468-1474.
2. 2 Spacek A, Neiger FX, Krenn CG et al. Rocuronium-induced neuromuscular block is affected by chronic carbamazepine therapy. Anesthesiology 1999; 90: 109-112.
3. 3 Platt PR, Thackray NM. Phenytoin-induced resistance to vecuronium. Anaesth Intens Care 1993; 21: 185-191.
4. 4 Pirttiaho HI, Sotaniemi EA, Pelkonen RO et al. Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants. Eur J Clin Pharmacol 1982; 22: 441-445.
5. 5 Brodie MJ, Dichter MA. Antiepileptic drugs. N Engl J Med 1996; 334: 168-175.
6. 6 Alloul K, Whalley DG, Shutway F et al. Pharmacokinetic origin of carbamazepine-induced resistance to vecuronium neuromuscular blockade in anesthetized patients. Anesthesiology 1996; 84: 330-339.
7. 7 Taivainen T, Meretoja OA, Erkola O et al. Rocuronium in infants, children and adults during balanced anaesthesia. Paed Anaesth 1996; 6: 271-275.
8. 8 Roth S, Ebrahim ZY. Resistance to pancuronium in patients receiving carbamazepine. Anesthesiology 1987; 66: 691-693.
9. 9 Szenohradszky J, Fisher DM, Segredo V et al. Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation. Anesthesiology 1992; 77: 899-904.
10. 10 Ornstein E, Matteo RS, Young WL et al. Resistance to metocurine-incluced neuromuscular blockade in patients receiving phenytoin. Anesthesiology 1985; 63: 294-298.
11. 11 Ornstein E, Matteo RS, Schwartz AE et al. The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium. Anesthesiology 1987; 67: 191-196.
12. 12 Spacek A, Neiger FX, Spiss CK et al. Atracurium-induced neuromuscular block is not affected by chronic anticonvulsant therapy with carbamazepine. Acta Anesthesiol Scand 1997; 41: 1308-1311.
13. 13 Spacek A, Neiger FX, Spiss CK et al. Chronic carbamazepine therapy does not influence mivacurium-induced neuromuscular blockade. Br J Anaesth 1996; 77: 500-502.
14. 14 Jellish WS, Thalji Z, Brundidge PK et al. Recovery from mivacurium-induced neuromuscular blockade is not affected by anticonvulsant therapy. J Neurosurg Anesthesiol 1996; 8: 4-8.
15. 15 Goudsouzian NG. Mivacurium in infants and children. Paed Anaesth 1997; 7: 183-190.
16. 16 Nation RL, Evans AM, Milne RW. Pharmacokinetic drug interactions with phenytoin, part 1. Clin Pharmacokinet 1990; 18: 37-60.
17. 17 Nation RL, Evans AM, Milne RW. Pharmacokinetic drug interactions with phenytoin, part 2. Clin Pharmacokinet 1990; 18: 131-150.